How Souroubea helps with anxiety in dogs

The dogs also experience anxiety, just like humans. Despite its unpleasant nature, anxiety in dogs is considered healthy and normal. Dog anxiety usually affects all strains, but its effect on individual dogs varies considerably. Although anxiety is a feeling that dogs regularly experience, leaving disproportionate anxiety levels unchecked can result in the dog developing anxiety disorder (Masic et al., 2018). Leaving dog anxiety untreated can result in behavioral and other issues in the dog. The three leading causes of dog anxiety mainly include aging, separation, and fear. Management of the diverse forms of anxiety varies considerably. However, the most commonly used medication for treating anxiety in dogs is Souroubea, which the paper explores its efficacy.  

The leading causes of fear-related anxiety include strange animals or people, loud noises, visual stimuli such as umbrellas or hats, strange or new surroundings, and particular circumstances, including car rides or vet office. Despite some dogs reportedly only experiencing short-term reactions to such stimuli, the situation tends to worsen amongst the anxious dogs.

Separation anxiety affects about 14% of dogs (Masic et al., 2021). Dogs experiencing anxiety because of separation are often incapable of finding comfort when alone or parted with their family members. Separation anxiety usually tends to show in unwanted behaviors, including defecating and urinating in the house, barking, and destroying furnishings and furniture. The other common form of anxiety in dogs is anxiety that draws from the old age of the dogs, common among older dogs and often associated with CDS (Masic et al., 2021). The dogs with CDS usually show symptoms that include declining awareness, perception, learning, and memory, similar to the initial stages of Alzheimer’s illness in individuals. The result encompasses anxiety and confusion in senior dogs. 

Souroubea is a genus of flowering plants in the family Marcgraviaceae, native to southern Mexico, Central America, Trinidad, and northern South America. It is a traditional native medicinal plant that exerts anxiolysis through interaction with the GABAA benzodiazepine receptor.

The clinical trials involving using Souroubea sympetalous extracts in treating anxiety in dogs revealed anxiolytic properties amongst animals (Murkar et al., 2019). The medication serves as an essential source of alternative treatment for anxiety in dogs. Masic et al.’s study mainly explored the efficiency of Souroubea-Platanus dietary supplement comprising triterpenes amongst anxious dogs (Masic et al., 2021).

The adopted substance for the test encompassed a new botanical dietary supplement, developed as an orally administered tablet that contains a set mixture of Platanus spp. and Souroubea spp. Vine. The test involved giving the substance in the form of canine anxiolytic stress induced by noise from the simulated thunderstorm. The study involved assessing the effectiveness of the medications in decreasing anxiety amongst the dogs in a blinded, placebo-controlled experiment by documenting the shifts in levels of cortisol in blood and evaluates their behavioral responses to the simulated thunder. The outcome of the study showed that Platanus spp. and Souroubea spp. Anxiolytic impacts in dogs through the inhibition of cortisol release and assistance in maintaining normal behavior in dogs. The findings also showed that the least efficient dosage in dogs is the presently suggested dosage. The test findings support using the medication as a natural and efficient anxiolytic for dogs when exposed to loud sounds. 

The oral administration of Souroubea-Platanus tablets is strongly recommended to reduce the biochemical and behavioral outcome measures assessing the sound of a thunderstorm on stress and anxiety in dogs. The botanical treatment of anxiety in dogs is quite recommended because of its essential role in increasing activity and reducing inactivity measures in all dogs. Souroubea-Platanus is a botanical treatment model for anxiety in doges associated with considerable dose-response impact on inactivity measures and an apparent dose-dependent trend in cortisol outcomes amongst the considered dogs. The findings of various studies encourage the use of Sourobea-Platanus tablets to reduce noise-induced anxiety amongst dogs by reducing the release of cortisol.

 

 

References

Masic, A., Landsberg, G., Milgram, B., Merali, Z., Durst, T., Sanchez Vindas, P., ... & Arnason, J. (2021). Efficacy of Souroubea-Platanus Dietary Supplement Containing Triterpenes in Beagle Dogs Using a Thunderstorm Noise-Induced Model of Fear and Anxiety. Molecules26(7), 2049.

Masic, A., Liu, R., Simkus, K., Wilson, J., Baker, J., Sanchez, P., ... & Arnason, J. T. (2018). Safety evaluation of a new anxiolytic product containing botanicals Souroubea spp. and Platanus spp. in dogs. Canadian Journal of Veterinary Research82(1), 3-11.

Murkar, A., Cayer, C., James, J., Durst, T., Arnason, J. T., Sanchez-Vindas, P. E., ... & Merali, Z. (2019). Extract and Active Principal of the Neotropical Vine Souroubea sympetala Gilg. Block Fear Memory Reconsolidation. Frontiers in Pharmacology10, 1496.

 

 

 

 

Dr. Jill Lopez

Dr. Jill Lopez is an award winning veterinary marketing professional that has worked with Fortune 500 companies, not for profit humane organizations, and global pet product manufacturers. She is a West Virginia native that now calls New Jersey her home.

https://www.linkedin.com/in/drjilllopez/
Previous
Previous

FDA issues final guidance on drug compounding

Next
Next

Restoring hormone levels in a neutered dog leads to health improvements